A groundbreaking study published in Cardiovascular Research unveils AB-Biotics’ AB-Life probiotic strains’ profound cardiometabolic benefits in combating atherosclerotic cardiovascular diseases (ACVDs). Led by AB-Biotics, the research demonstrates how AB-Life, containing Lactiplantibacillus plantarum strains, reduces LDL particle sizes and apolipoproteins, pivotal biomarkers in atherosclerosis development. The study highlights the probiotics’ role in bile acid metabolism, lowering LDL-C and ApoB protein levels, while also improving gut microbiota composition and offering protection against dyslipidemia. This discovery underscores the potential of probiotics in enhancing cardiovascular health and prompts further investigation into their therapeutic applications.
Home » AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Astragalus Polysaccharides: A Multi-Targeted Approach to Obesity Management
September 20, 2025
Paprika Xanthophylls (PXs) Boost Endurance & Cognitive Function
September 20, 2025

From Gut to Follicle: New Trial Links Microbiome to Hair Density
September 20, 2025